Serviços Personalizados
Journal
Artigo
Espanhol (pdf)
Artigo em XML
Referências do artigo
Tradução automática
Enviar este artigo por emailIndicadores
Citado por SciELO 
Acessos
Links relacionados
Citado por Google 
Similares em
SciELO 
Similares em Google
Compartilhar
Permalink
Revista de la Facultad de Medicina
versão impressa ISSN 0120-0011
Resumo
ESCOBAR, Hellmann Adrián et al. Pharmacological treatment of Kawasaki disease. rev.fac.med. [online]. 2019, vol.67, n.1, pp.103-108. ISSN 0120-0011. https://doi.org/10.15446/revfacmed.v67n1.64144.
Introduction:
Kawasaki disease is a systemic vasculitis of unknown origin and its main complication is the formation of coronary aneurysms.
Objective:
To conduct an updated review of the literature on the pharmacological treatment of Kawasaki disease.
Materials and methods:
A structured literature search was conducted in the ProQuest, EBSCO, ScienceDirect, PubMed, LILACS, Embase, Trip Database, SciELO and Cochrane Library databases with the terms "Kawasaki disease AND therapeutics", "Kawasaki disease AND treatment" and "Mucocutaneous Lymph Node Syndrome AND therapeutics", in English and their equivalents in Spanish.
Results:
51 articles were found with information relevant for this review.
Conclusions:
Early diagnosis and treatment of Kawasaki disease is essential to prevent coronary complications. Treatment includes combined therapy with acetylsalicylic acid plus immunoglobulin G, which reduces the incidence of coronary aneurysms. On the other hand, corticosteroid therapies and other immunosuppressive drugs are alternatives used to treat immunoglobulin-resistant Kawasaki disease.
Palavras-chave : Kawasaki Disease; Drug Therapy; Therapeutic; Mucocutaneous Lymph Node Syndrome (MeSH).
